Your browser doesn't support javascript.
loading
Interferon treatment in children with chronic hepatitis C: long-lasting remission in responders, and risk for disease progression in non-responders.
Bortolotti, F; Iorio, R; Nebbia, G; Marcellini, M; Giacchino, R; Zancan, L; Gussetti, N; Barbera, C; Maccabruni, A; Verucchi, G; Balli, F; Vegnente, A; Guido, M; Bartolacci, S.
Afiliación
  • Bortolotti F; Clinica Medica 5, University, Padua, Italy. flavia.bortolotti@unipd.it
Dig Liver Dis ; 37(5): 336-41, 2005 May.
Article en En | MEDLINE | ID: mdl-15843083
BACKGROUND AND AIM: Large interferon-based therapeutic trials are still lacking in children with hepatitis C and the long-term safety and efficacy of interferon is unknown. This study describes the outcome of hepatitis C in 43 children enrolled in an open-label interferon trial, and were followed up to 66 months after stopping treatment. PATIENTS AND METHODS: All patients received interferon alfa2a (5MU/m(2)) thrice weekly for 6 months; children with genotype 1b received 3MU/m(2) thrice weekly for 6 additional months. RESULTS: Nine children discontinued interferon for adverse events and three were not compliant to treatment. Eight (19%, intention to treat analysis), including 2/20 (10%) with genotype 1b and 6/12 (50%) with genotypes 2 or 3, were sustained responders 12 months after stopping therapy. During further follow-up (mean+/-S.D.: 44.7+/-14.6 months), response was maintained; two non-responders cleared viremia, while a young boy progressed to cirrhosis. CONCLUSIONS: Small sample size and therapy withdrawal are the major limitations in the interpretation of our results. Nevertheless, our data, suggesting that response to interferon in children with hepatitis C is genotype-related and stable, agree with the results of large studies in adults. The outcome in non-responders was variable, including persistence of viremia and mild-moderate cytolysis (most cases), progression to cirrhosis, or eventual sustained viremia clearance.
Asunto(s)
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Interferón-alfa / Hepatitis C Crónica Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Adolescent / Female / Humans / Male Idioma: En Revista: Dig Liver Dis Asunto de la revista: GASTROENTEROLOGIA Año: 2005 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Países Bajos
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Interferón-alfa / Hepatitis C Crónica Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Adolescent / Female / Humans / Male Idioma: En Revista: Dig Liver Dis Asunto de la revista: GASTROENTEROLOGIA Año: 2005 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Países Bajos